# Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds

> **NCT02918721** · NA · COMPLETED · sponsor: **Galderma R&D** · enrollment: 70 (actual)

## Conditions studied

- Nasolabial Fold

## Interventions

- **DEVICE:** Restylane Lidocaine
- **DEVICE:** Restylane

## Key facts

- **NCT ID:** NCT02918721
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-08
- **Primary completion:** 2017-04-27
- **Final completion:** 2017-05-11
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918721, "Pain and Safety of Restylane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02918721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*